p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics

BACKGROUND: The KRAS exon 2 p. G12C mutation in patients with lung adenocarcinoma has been increasing in relevance due to the development and effectiveness of new treatment medications. Studies around different populations indicate that regional variability between ethnic groups and ancestries could...

Descripción completa

Detalles Bibliográficos
Autores principales: Ruiz-Patiño, Alejandro, Rodríguez, July, Cardona, Andrés F., Ávila, Jenny, Archila, Pilar, Carranza, Hernán, Vargas, Carlos, Otero, Jorge, Arrieta, Oscar, Zatarain-Barrón, Lucia, Sotelo, Carolina, Ordoñez, Camila, García-Robledo, Juan Esteban, Rojas, Leonardo, Bermúdez, Maritza, Gámez, Tatiana, Mayorga, Diana, Corrales, Luis, Martín, Claudio, Recondo, Gonzalo, Mas, Luis, Samtani, Suraj, Ricaurte, Luisa, Malapelle, Umberto, Russo, Alessandro, Barrón, Feliciano, Santoyo, Nicolas, Rolfo, Christian, Rosell, Rafael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626684/
https://www.ncbi.nlm.nih.gov/pubmed/34823093
http://dx.doi.org/10.1016/j.tranon.2021.101276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8626684/
https://www.ncbi.nlm.nih.gov/pubmed/34823093
http://dx.doi.org/10.1016/j.tranon.2021.101276

Ejemplares similares